CME Group Inc. (NASDAQ:CME – Get Free Report) Director Howard J. Siegel sold 10,000 shares of the company’s stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the completion of the transaction, the director now owns 21,873 shares in the company, valued at $5,686,980. This represents a 31.37 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
CME Group Stock Up 1.1 %
Shares of CME Group stock opened at $266.49 on Wednesday. The stock has a market capitalization of $96.03 billion, a P/E ratio of 27.56, a PEG ratio of 6.76 and a beta of 0.53. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The stock has a 50 day moving average price of $244.35 and a two-hundred day moving average price of $233.28. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $266.63.
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a return on equity of 13.62% and a net margin of 57.52%. Equities analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.
CME Group Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Friday, March 7th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.88%. This is a boost from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio is currently 51.71%.
Wall Street Analyst Weigh In
CME has been the topic of a number of research reports. JPMorgan Chase & Co. upped their target price on CME Group from $209.00 to $212.00 and gave the company an “underweight” rating in a report on Thursday, February 13th. Citigroup downgraded CME Group from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $255.00 to $250.00 in a report on Monday, January 6th. Keefe, Bruyette & Woods increased their price objective on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a report on Friday, February 14th. Royal Bank of Canada increased their price objective on CME Group from $235.00 to $269.00 and gave the stock a “sector perform” rating in a report on Thursday, February 13th. Finally, Piper Sandler increased their price objective on CME Group from $250.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, January 7th. Four analysts have rated the stock with a sell rating, eight have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, CME Group presently has a consensus rating of “Hold” and a consensus price target of $238.93.
View Our Latest Analysis on CME Group
Institutional Investors Weigh In On CME Group
Hedge funds have recently modified their holdings of the business. Truvestments Capital LLC bought a new stake in shares of CME Group in the third quarter valued at approximately $26,000. SJS Investment Consulting Inc. raised its stake in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 97 shares in the last quarter. Dunhill Financial LLC raised its stake in shares of CME Group by 188.4% in the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares in the last quarter. New Age Alpha Advisors LLC raised its stake in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares in the last quarter. Finally, Financial Life Planners acquired a new position in shares of CME Group in the fourth quarter valued at $32,000. 87.75% of the stock is owned by institutional investors.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Investing in Construction Stocks
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- What Are Dividend Achievers? An Introduction
- 3 Must-Own Stocks to Build Wealth This Decade
- What is diluted earnings per share (Diluted EPS)?
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.